Annexon
ANNX | NASDAQ
$3.57
-$0.35 (-8.93%)
At close: Nov 16, 2026, 4:00 PM ET
$3.62
+$0.05 (+1.40%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-8.93%
(1D)No price chart data available for 1D timeframe.
Rating
31
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #771/1021 (Top 76%)
Key Statistics
Market Data
Market Cap $730.61M
1D Range
3.55 3.91
52W Range
3.02 6.96
Valuation (TTM)
PE -3.43
PB 5.12
EV/EBITDA -3.02
Valuation (NTM)
Forward PE N/A
Forward PEG 0.14
Price Target $14.00
Cash Flow
FCF Yield -25.9%
SBC Adj. FCF Yield -28.3%
SBC Impact -9.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 0.4% |
29.0%
FCF 3Y | 5Y -26.7% |
-12.6%
Returns
ROA -79.5%
ROE -106.8%
ROIC -95.3%
Financial Health
Net Cash
$164.03M
Current Ratio 5.79
Interest Coverage -247.03
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmi...
Sector Healthcare
Industry Biotechnology
Employees 92
IPO Date Jul 24, 2020
Website www.annexonbio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
6
Consensus
Buy
Price Target
$14.00
Upside
+292.16%
Buy (5)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ANNX